CliniGA CRO

CliniGA CRO Blog

Separating sponsor start-up readiness from site readiness

Site preparation can draw attention away from the sponsor's own decision, system and support arrangements.

Representative research photograph: Separating sponsor start-up readiness from site readiness
Photo: U.S. Army photo by Pvt. Samuel Signor · License: Public domain · Cropped and resized.
Published
Updated

Site preparation can draw attention away from the sponsor's own decision, system and support arrangements. Training may be complete while the route for answering a site question remains unready. A sponsor readiness check makes these reciprocal dependencies visible before the relevant trial activity starts.

Decision framework

Examine critical communications, product and data services, authorised decision owners and sponsor-provided inputs. Keep sponsor internal readiness distinct from site-release conditions. Commercial project launch does not establish completion of necessary ethical and regulatory requirements; the applicable confirmations remain with their authorised processes and responsible owners.

Worked example

For example, a site completes all training but the weekend technical support route has not been tested. When the first important system issue occurs, staff do not know whom to contact. A sponsor check tests routing through a realistic question and fixes the gap before launch. That provides stronger evidence than marking a checklist box alone.

Implementation checks

  • Map sponsor responses needed during a site's first participant workflow together with the relevant people responsible for providing them.
  • Test critical system, product and safety communication routes through appropriate examples using authorised access and realistic conditions.
  • Record which activity an open readiness gap would prevent and identify the owner responsible for closing that gap.

Acceptance and boundaries

Accept readiness when essential workflows can continue and unresolved critical gaps are managed appropriately. Open items differ in importance, so assess participant and data consequences. A general start-up approval does not remove the responsibility to examine new risks that emerge after activities begin at the site.

Frequently asked questions

Is site readiness sufficient on its own?
No. Necessary sponsor services and decision routes also need to be workable.
Does a checklist alone provide proof?
A checklist helps, but appropriate records should demonstrate that necessary workflows actually function.

Sources

  1. EMA — ICH E6 good clinical practice
  2. WHO — Guidance for best practices for clinical trials